Transcription factor activator protein 1 (AP1) interacts with the promoter region of a number of genes that are stimulated by growth factors present in serum or by agents such as phorbol 12-myristate 13-acetate (PMA) that partially mimic their action. To investigate the possible role of API in the control of cellular growth and in transformation of mammalian cells, we monitored its activity by binding to a specific DNA probe in normal or transformed mouse NIH 3T3 cells. A 3-to 4-fold increase in the DNA-binding activity was found after serum stimulation of quiescent NIH 3T3 cells. A 2-to 3-fold activation was found after treatment with PMA or dibutyryl-cAMP, suggesting that different signal-transducing pathways could activate API factor in these cells. PMA stimulation was dependent on new protein synthesis. In contrast to normal cells, a high serum-independent APi DNAbinding activity was found in NIH 3T3 cells transformed by simian virus 40. These results suggest that constitutive APi synthesis may be a crucial step in cellular transformation.
serum or defined mitogens leads to resumption of DNA synthesis and cell division. Ample evidence indicates that transformed cells lose at least partially the dependence on growth factors (1).
It is generally assumed that stimulation of quiescent cells by growth factors ultimately results in the activation of specific transcription factors, which could in turn activate the genes involved in the many aspects of cellular proliferation (2) . This stimulation would occur through signal-transducing pathways, such as the protein kinase C pathway, which can be artificially stimulated by the phorbol ester phorbol 12-myristate 13 -acetate (PMA) (3) . Another pathway involves activation of protein kinase A by an increase in intracellular cAMP concentration. cAMP levels can be artificially increased by addition of N6,02'-dibutyryl-cAMP (Bt2cAMP) to the medium, by addition of forskolin (an activator of adenylate cyclase), or by addition of 3-isobutyl-1-methylxanthine (iBuMeXan; an inhibitor of the phosphodiesterase) (4) .
Transcription of nuclear protooncogenes, such as c-fos or c-myc, is transiently activated after growth stimulation of quiescent NIH 3T3 cells, and this activation does not require de novo protein synthesis (5) . Thus, a first step in growth stimulation could involve post-translational modification, perhaps phosphorylation, of preexisting transcription factors such as the serum-responsive factor (SRF) that interact with the c-fos or 8-actin promoter (6) (7) (8) . These factors could activate the transcription not only of c-fos or c-myc but of a whole class of immediate early or competence genes, some of them encoding factors needed for the expression of delayed early genes. The expression of this second class of genes, which could include still another group of transcription factors, would precede DNA synthesis (9) . The transcription factor activator protein 1 (AP1), recently characterized in HeLa cell extracts, may play a role in growth control. AP1 interacts with the enhancer of the human metallothionein gene and that of simian virus 40 (SV40) (10) .
The mouse counterpart of this protein, which we have previously termed PEAl (polyoma enhancer A binding protein 1), interacts with the polyomavirus, SV40, and c-fos gene enhancers (11) . AP1 or PEAl sites were recently found in the transcription control sequences of many genes that are stimulated by serum, growth factors, or oncogenic transformation (refs. 12 and 13; S. Saragosti and J.P., unpublished data). A minimal AP1 binding site was shown to enhance transcription from a heterologous promoter in vitro and to confer PMA responsiveness to a heterologous promoter in vivo (12, 13) . As PEA1 and AP1 probably belong to the same family of factors, we will deal in the following text with AP1 exclusively, designating a factor or family of factors with the sequence specificity of AP1.
The AP1 site present in the a domain of the polyomavirus enhancer is crucial both for replication and early promoter activity of this virus (J.P. and W. R. Folk, unpublished data). Moreover, the absence of activity of the polyomavirus A enhancer in embryonal carcinoma cells has been correlated with the absence of detectable DNA-binding activity of AP1 in these cells (14) . Cotransfection of polyomavirus with v-Ha-ras activates the polyomavirus enhancer in embryonal carcinoma and myeloma cells; the same effect is also obtained in myeloma cells after PMA treatment (15 
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Proc. Natl. Acad. Sci. USA 85 (1988) indicated in the legend of Fig. 2 . Cells were collected after 2 hr of stimulation.
Preparation of Cell Extracts. Nuclear extracts were prepared as described in ref. 17 . Briefly, the cells were rinsed twice with phosphate-buffered saline and kept on ice. The content of 20 dishes (9 cm in diameter) was resuspended in 5 ml of buffer A (10 mM Hepes, pH 8/50 mM NaCl/0.5 M sucrose/i mM EDTA/0.5 mM spermidine/0.15 mM spermine/0.5% Triton X-100/1 mM phenylmethylsulfonyl fluoride/7 mM 2-mercaptoethanol). The cells were disrupted in a Dounce homogenizer by 20 strokes with an A pestle, and the nuclei were collected by centrifugation for 10 min at 1000 x g. The nuclear pellet was rinsed twice with 5 ml of buffer A and resuspended in 2 ml of buffer B containing 100 mM NaCl [buffer B is 10 mM Hepes, pH 8/25% (vol/vol) glycerol/0.1 mM EDTA/0.5 mM spermidine/0.15 mM spermine/1 mM phenylmethylsulfonyl fluoride/7 mM 2-mercaptoethanol]. After 15 min of gentle agitation the nuclei were centrifuged at 1000 x g and resuspended in 2 ml of buffer B containing 500 mM NaCl. After 30 min of gentle agitation, the nuclei were centrifuged at 2000 x g and the supernatant was brought to 45% saturation with (NH4)2SO4. Proteins were precipitated by centrifugation for 30 min at 10,000 x g. The pellet was resuspended in 100 t1t of buffer B containing 100 mM NaCl.
Whole cell extracts were prepared as described in ref. (Fig. 2b, lane a) (Fig. 2a) . NF-I is a ubiquitous factor involved in the transcription and replication of a number of genes and viruses (22) . Some variation was noticed in the relative intensity of the different bands constituting the NF-I retardation pattern; however, the overall amount of retarded oligonucleotide was nearly identical in the different samples of one experiment. The stimulation values for AP1 binding given in Table 1 Constitutive AP1 Activity in Transformed NIH 3T3 Cells. If the level of AP1 transcription factor plays an important role in the regulation of cell proliferation, the question arises as to whether cellular transformation will modify the regulation of its synthesis. In other words, do transformed NIH 3T3 cells display a high, serum-independent, level of AP1-binding activity? To answer this question, we prepared nuclear extracts from NIH 3T3 cells stably transformed by SV40 that were serum starved (0.5% serum) for 2 days, or stimulated by 15% serum for 2 additional hr. As shown in Fig. 3 and Table  1 , AP1 activity is high in transformed cells, and this high level is not strongly decreased in conditions of serum starvation. No difference was observed in NF-I activity between serumstarved NIH 3T3 cells and virally transformed cells either in the absence or in the presence of serum.
DISCUSSION
AP1 is involved in the transcriptional regulation of a large number of cellular genes, many of which are subject to control by growth or transformation (10-13). The experiments described here deal with the regulation of AP1 activity. We show that the DNA-binding activity of the AP1 factor is increased in quiescent NIH 3T3 cells by serum mitogens. On the other hand, the concentration of transcription factor NF-I, as detected by DNA binding, is almost independent of serum concentration, suggesting that the increase in AP1 transcription factor is directly correlated with increased gene activity. The effect of serum on AP1 activity can be partially mimicked by phorbol esters or by an increase in intracellular cAMP. Although PMA and cAMP have different effects on cellular metabolism, they work synergistically to promote cellular division in Swiss 3T3 cells (23 (24) .
The block of AP1 activation by translational inhibitors seems to argue against activation by direct modification of a preexisting factor as suggested for NFKB transcription factor activation in pre-B cells (25) . Early translation-independent events after serum stimulation, like c-fos induction, may be a prerequisite for AP1 activation after de novo protein synthesis. The partial overlap of the AP1 site with the serum-responsive element mapped by Treisman in the c-fos promoter suggests that AP1 may participate in a later step of c-fos transcriptional regulation (11, 26) . AP1 may also be involved in the delayed activation of genes such as that for ornithine decarboxylase, an activation that requires new protein synthesis (27) . In contrast to our observations with NIH 3T3 cells, AP1 activation by PMA was not sensitive to translational inhibitors in human HeLa tk-or HepG2 cells (12, 13) . AP1 synthesis may be already constitutive in these cells, which were originally derived from tumors. The DNAbinding activity of AP1 would then be modulated by posttranslational modifications. On the other hand, the regulation in NIH 3T3 cells could occur at the transcriptional level or at the level of RNA stability or processing. However, we cannot exclude that mitogen induction in NIH 3T3 cells involved covalent modification in addition to de novo synthesis.
Since AP1 activity seems to be directly related to cellular proliferation it is of interest to monitor its activity in transformed cells. We showed that in SV40-transformed NIH 3T3 cells this activity is constitutively higher than in NIH 3T3 cells and is independent of serum concentration. Even in the presence of 0.5% serum in the growth medium these cells contain almost the same level of AP1 DNA-binding activity as normal NIH 3T3 cells stimulated with 15% serum. Cellular transformation is a complex multistep process, and a constitutive expression of AP1 may represent one of the crucial requirements for cellular transformation (28 
